BRIEF-Shanghai Pharma Expects 2019 Net Profit To Decrease Due To Impairment Provision

March 20 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd :

* SAYS IT SETS ASIDE PROVISION FOR GOOD-WILL IMPAIRMENT, EXPECTS TO REDUCE 2019 NET PROFIT BY 477.5 MILLION YUAN ($67.68 million) Source text in Chinese: Further company coverage: ($1 = 7.0555 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)